These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 38243954)

  • 21. Gut microbiome and type 2 diabetes: where we are and where to go?
    Sharma S; Tripathi P
    J Nutr Biochem; 2019 Jan; 63():101-108. PubMed ID: 30366260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gut-Microbial Metabolites, Probiotics and Their Roles in Type 2 Diabetes.
    Zhai L; Wu J; Lam YY; Kwan HY; Bian ZX; Wong HLX
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unravelling the Crosstalk between Estrogen Deficiency and Gut-biotaDysbiosis in the Development of Diabetes Mellitus.
    Rishabh ; Bansal S; Goel A; Gupta S; Malik D; Bansal N
    Curr Diabetes Rev; 2024; 20(10):e240124226067. PubMed ID: 38275037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unravelling the involvement of gut microbiota in type 2 diabetes mellitus.
    Arora A; Behl T; Sehgal A; Singh S; Sharma N; Bhatia S; Sobarzo-Sanchez E; Bungau S
    Life Sci; 2021 May; 273():119311. PubMed ID: 33662428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolites of Gut Microbiota and Possible Implication in Development of Diabetes Mellitus.
    Guo Z; Pan J; Zhu H; Chen ZY
    J Agric Food Chem; 2022 May; 70(20):5945-5960. PubMed ID: 35549332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of Gut Microbiota on Onset and Progression of Microvascular Complications of Type 2 Diabetes (T2DM).
    Tanase DM; Gosav EM; Neculae E; Costea CF; Ciocoiu M; Hurjui LL; Tarniceriu CC; Maranduca MA; Lacatusu CM; Floria M; Serban IL
    Nutrients; 2020 Dec; 12(12):. PubMed ID: 33276482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring the Significance of Gut Microbiota in Diabetes Pathogenesis and Management-A Narrative Review.
    Młynarska E; Wasiak J; Gajewska A; Steć G; Jasińska J; Rysz J; Franczyk B
    Nutrients; 2024 Jun; 16(12):. PubMed ID: 38931292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intermittent hypoxia is involved in gut microbial dysbiosis in type 2 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome.
    Tang SS; Liang CH; Liu YL; Wei W; Deng XR; Shi XY; Wang LM; Zhang LJ; Yuan HJ
    World J Gastroenterol; 2022 Jun; 28(21):2320-2333. PubMed ID: 35800187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut microbiota dysbiosis in polycystic ovary syndrome: Mechanisms of progression and clinical applications.
    Sun Y; Gao S; Ye C; Zhao W
    Front Cell Infect Microbiol; 2023; 13():1142041. PubMed ID: 36909735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Microbiome, diabetes and heart: a novel link?].
    Kappel BA; Lehrke M
    Herz; 2019 May; 44(3):223-230. PubMed ID: 30847506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. From role of gut microbiota to microbial-based therapies in type 2-diabetes.
    Ebrahimzadeh Leylabadlo H; Sanaie S; Sadeghpour Heravi F; Ahmadian Z; Ghotaslou R
    Infect Genet Evol; 2020 Jul; 81():104268. PubMed ID: 32126303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gut Microbiome and Its Impact on Obesity and Obesity-Related Disorders.
    Sankararaman S; Noriega K; Velayuthan S; Sferra T; Martindale R
    Curr Gastroenterol Rep; 2023 Feb; 25(2):31-44. PubMed ID: 36469257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Balancing Act: Exploring the Gut Microbiota-Brown Adipose Tissue Axis in PCOS Pathogenesis and Therapeutic Frontiers.
    Li Y; Fang Y; Wang H; Zhang H
    Front Biosci (Landmark Ed); 2024 May; 29(6):208. PubMed ID: 38940030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting gut microbiota as a possible therapy for diabetes.
    He C; Shan Y; Song W
    Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CX3CR1 regulates gut microbiota and metabolism. A risk factor of type 2 diabetes.
    Pomié C; Servant F; Garidou L; Azalbert V; Waget A; Klopp P; Garret C; Charpentier J; Briand F; Sulpice T; Lelouvier B; Douin-Echinard V; Burcelin R
    Acta Diabetol; 2021 Aug; 58(8):1035-1049. PubMed ID: 33754166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gut Microbiota: From Microorganisms to Metabolic Organ Influencing Obesity.
    Stephens RW; Arhire L; Covasa M
    Obesity (Silver Spring); 2018 May; 26(5):801-809. PubMed ID: 29687647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gut Microbiota and Type 1 Diabetes.
    Han H; Li Y; Fang J; Liu G; Yin J; Li T; Yin Y
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29584630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered Gut Microbiota in Type 2 Diabetes: Just a Coincidence?
    Sircana A; Framarin L; Leone N; Berrutti M; Castellino F; Parente R; De Michieli F; Paschetta E; Musso G
    Curr Diab Rep; 2018 Sep; 18(10):98. PubMed ID: 30215149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A State-of-Art Review of the Vicious Circle of Sleep Disorders, Diabetes and Neurodegeneration Involving Metabolism and Microbiota Alterations.
    Versace S; Pellitteri G; Sperotto R; Tartaglia S; Da Porto A; Catena C; Gigli GL; Cavarape A; Valente M
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.